New diagnostic and therapeutic tools combining nanotechnology have been developed in recent medical research, which are beneficial to the specific transport and absorption of drugs and contrast agents to the brain, as well as promoting the regeneration of damaged neurons to limit or reverse neurological disorders. As a common neurological condition, dementia affected 46.8 million individuals globally in 2015, with that figure expected to rise to 131.5 million by 2050. Early identification is critical for efficient treatment of AD since neuro invasiveness and degenerative changes begin before the onset of symptoms. To detect and identify amyloid plaques, most investigations use magnetic resonance imaging (MRI) using contrast-doped NPs or tagging NPs with fluorescent probes. To combat neurodegenerative disorders, nanotechnology can be applied into neuroscience.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China